Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mamoru Watanabe

Showing results (371-380 of 510) with videos related to

Pageof 51
Sort By:
Clinical Journal of Gastroenterology|July 18, 2015
Primary hepatic neuroendocrine carcinoma with a cholangiocellular carcinoma component in one noduleYoshihito Kano, Sei Kakinuma, Fumio Goto, et al.
The Journal of General Virology|November 21, 2007
Hepatitis C virus non-structural proteins responsible for suppression of the RIG-I/Cardif-induced interferon responseMegumi Tasaka, Naoya Sakamoto, Yoshie Itakura, et al.
Stem Cell Research & Therapy|March 29, 2026
Peptide-based Wnt signal activation enables scalable production of clinical-grade patient-derived intestinal organoids for regenerative cell therapyHady Yuki Sugihara, Sayaka Nagata, Sho Kawasaki, et al.
Gastroenterology|June 9, 2005
Increase of bone marrow-derived secretory lineage epithelial cells during regeneration in the human intestineTomoko Matsumoto, Ryuichi Okamoto, Tomoharu Yajima, et al.
Biochemical and Biophysical Research Communications|January 22, 2021
Nickel ions attenuate autophagy flux and induce transglutaminase 2 (TG2) mediated post-translational modification of SQSTM1/p62Emi Aonuma, Akiko Tamura, Hiroki Matsuda, et al.
Scientific Reports|November 10, 2016
PGE<sub>2</sub> is a direct and robust mediator of anion/fluid secretion by human intestinal epithelial cellsSatoru Fujii, Kohei Suzuki, Ami Kawamoto, et al.
Cancer Science|May 29, 2015
Atonal homolog 1 protein stabilized by tumor necrosis factor α induces high malignant potential in colon cancer cell lineKeita Fukushima, Kiichiro Tsuchiya, Yoshihito Kano, et al.
The Lancet. Gastroenterology & Hepatology|April 22, 2021
Discontinuation of infliximab in patients with ulcerative colitis in remission (HAYABUSA): a multicentre, open-label, randomised controlled trialTaku Kobayashi, Satoshi Motoya, Shiro Nakamura, et al.
Inflammatory Bowel Diseases|October 12, 2011
Retrieval of serum infliximab level by shortening the maintenance infusion interval is correlated with clinical efficacy in Crohn's diseaseToshifumi Hibi, Atsushi Sakuraba, Mamoru Watanabe, et al.
The Lancet. Gastroenterology & Hepatology|April 2, 2022
AJM300 (carotegrast methyl), an oral antagonist of α4-integrin, as induction therapy for patients with moderately active ulcerative colitis: a multicentre, randomised, double-blind, placebo-controlled, phase 3 studyKatsuyoshi Matsuoka, Mamoru Watanabe, Toshihide Ohmori, et al.
Pageof 51

Showing results (371-380 of 510) with videos related to

Sort By:
Pageof 51
Clinical Journal of Gastroenterology|July 18, 2015
Primary hepatic neuroendocrine carcinoma with a cholangiocellular carcinoma component in one noduleYoshihito Kano, Sei Kakinuma, Fumio Goto, et al.
The Journal of General Virology|November 21, 2007
Hepatitis C virus non-structural proteins responsible for suppression of the RIG-I/Cardif-induced interferon responseMegumi Tasaka, Naoya Sakamoto, Yoshie Itakura, et al.
Stem Cell Research & Therapy|March 29, 2026
Peptide-based Wnt signal activation enables scalable production of clinical-grade patient-derived intestinal organoids for regenerative cell therapyHady Yuki Sugihara, Sayaka Nagata, Sho Kawasaki, et al.
Gastroenterology|June 9, 2005
Increase of bone marrow-derived secretory lineage epithelial cells during regeneration in the human intestineTomoko Matsumoto, Ryuichi Okamoto, Tomoharu Yajima, et al.
Biochemical and Biophysical Research Communications|January 22, 2021
Nickel ions attenuate autophagy flux and induce transglutaminase 2 (TG2) mediated post-translational modification of SQSTM1/p62Emi Aonuma, Akiko Tamura, Hiroki Matsuda, et al.
Scientific Reports|November 10, 2016
PGE<sub>2</sub> is a direct and robust mediator of anion/fluid secretion by human intestinal epithelial cellsSatoru Fujii, Kohei Suzuki, Ami Kawamoto, et al.
Cancer Science|May 29, 2015
Atonal homolog 1 protein stabilized by tumor necrosis factor α induces high malignant potential in colon cancer cell lineKeita Fukushima, Kiichiro Tsuchiya, Yoshihito Kano, et al.
The Lancet. Gastroenterology & Hepatology|April 22, 2021
Discontinuation of infliximab in patients with ulcerative colitis in remission (HAYABUSA): a multicentre, open-label, randomised controlled trialTaku Kobayashi, Satoshi Motoya, Shiro Nakamura, et al.
Inflammatory Bowel Diseases|October 12, 2011
Retrieval of serum infliximab level by shortening the maintenance infusion interval is correlated with clinical efficacy in Crohn's diseaseToshifumi Hibi, Atsushi Sakuraba, Mamoru Watanabe, et al.
The Lancet. Gastroenterology & Hepatology|April 2, 2022
AJM300 (carotegrast methyl), an oral antagonist of α4-integrin, as induction therapy for patients with moderately active ulcerative colitis: a multicentre, randomised, double-blind, placebo-controlled, phase 3 studyKatsuyoshi Matsuoka, Mamoru Watanabe, Toshihide Ohmori, et al.
Pageof 51